Steven Pieper
Director of Finance/CFO at XERIS BIOPHARMA HOLDINGS, INC.
Net worth: 658 079 $ as of 2024-04-29
Steven Pieper active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Director of Finance/CFO | 2021-09-30 | - |
Career history of Steven Pieper
Former positions of Steven Pieper
| Companies | Position | Start | End |
|---|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Chief Operating Officer | 2014-12-31 | 2016-12-31 |
| Director of Finance/CFO | 2014-12-31 | 2016-12-31 | |
| DURATA THERAPEUTICS INC | Director of Finance/CFO | - | - |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Comptroller/Controller/Auditor | 2021-07-27 | - |
| Director/Board Member | 2021-10-04 | - | |
| Director of Finance/CFO | 2021-07-27 | - | |
| Corporate Officer/Principal | 2016-12-31 | 2021-07-27 |
Training of Steven Pieper
| DePaul University | Undergraduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Director of Finance/CFO | 4 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Steven Pieper
- Experience
